Novo Nordisk A/S (NONOF)
128.75
+1.03
(+0.81%)
USD |
OTCM |
May 10, 16:00
Novo Nordisk EPS Diluted (Quarterly): 1.261 for June 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 1.261 |
| March 31, 2023 | 1.266 |
| December 31, 2022 | 0.4152 |
| September 30, 2022 | 0.8583 |
| June 30, 2022 | 0.8389 |
| March 31, 2022 | 0.9383 |
| December 31, 2021 | 0.3626 |
| September 30, 2021 | 0.8355 |
| June 30, 2021 | 0.8524 |
| March 31, 2021 | 0.8835 |
| December 31, 2020 | 0.3176 |
| September 30, 2020 | 0.6944 |
| June 30, 2020 | 0.669 |
| March 31, 2020 | 0.7455 |
| December 31, 2019 | 0.2692 |
| September 30, 2019 | 0.6391 |
| June 30, 2019 | 0.6063 |
| March 31, 2019 | 0.6636 |
| December 31, 2018 | 0.2651 |
| September 30, 2018 | 0.5832 |
| June 30, 2018 | 0.6826 |
| March 31, 2018 | 0.7259 |
| December 31, 2017 | 0.2612 |
| September 30, 2017 | 0.6258 |
| June 30, 2017 | 0.5929 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.5816 |
| December 31, 2016 | 0.5017 |
| September 30, 2016 | 0.5803 |
| June 30, 2016 | 0.5951 |
| March 31, 2016 | 0.5485 |
| December 31, 2015 | 0.2329 |
| September 30, 2015 | 0.4855 |
| June 30, 2015 | 0.4783 |
| March 31, 2015 | 0.574 |
| December 31, 2014 | 0.2067 |
| September 30, 2014 | 0.4392 |
| June 30, 2014 | 0.4888 |
| March 31, 2014 | 0.4461 |
| December 31, 2013 | 0.2008 |
| September 30, 2013 | 0.4247 |
| June 30, 2013 | 0.4362 |
| March 31, 2013 | 0.3893 |
| December 31, 2012 | 0.1787 |
| September 30, 2012 | 0.3468 |
| June 30, 2012 | 0.334 |
| March 31, 2012 | 1.467 |
| December 31, 2011 | 0.1464 |
| September 30, 2011 | 0.2803 |
| June 30, 2011 | 0.2783 |
| March 31, 2011 | 0.2591 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
0.2692
Minimum
Dec 2019
1.266
Maximum
Mar 2023
0.7326
Average
0.7455
Median
Mar 2020
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly and Co | 2.48 |
| Genmab A/S | 0.2939 |
| Ascendis Pharma A/S | -2.498 |
| Galecto Inc | -0.20 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.839B |
| Revenue (Quarterly) | 7.936B |
| Total Expenses (Quarterly) | 4.445B |
| Gross Profit Margin (Quarterly) | 85.53% |
| Profit Margin (Quarterly) | 35.78% |